WT1 contributes to leukemogenesis: Expression patterns in 7,12- dimethylbenz[a]anthracene (DMBA)-induced leukemia

International Journal of Cancer

Volumn 72, Issue 4, 1997, Pages 696-699

  Osaka, Mitsuhiko ^a   Koami, Kenichi ^a   Sugiyama, Taketoshi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Shiga Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; LEUKEMIA; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; COCARCINOGENESIS; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, RAS; GENES, WILMS TUMOR; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MUTATION; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED STRAINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WT1 PROTEINS;

EID: 0030785683     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970807)72:4<696::AID-IJC23>3.0.CO;2-8     Document Type: Article

References (30)

1. ALGAR, E., BLACKBURN, D., KHROMYKH, T., TAYLOR, G. and SMITH. P., Mutation analysis of the WT1 gene in sporadic childhood leukaemia. Leukemia, 11, 110-113 (1997).
2. ALGAR, E.M., KHROMYKH, T., SMITH, S.I., BLACKBURN, D.M., BRYSON, G.J. and SMITH, P.J., AWT1 anti-sense oligonucleotide inhibits proliferation and induces apoptosis in myeloid-leukaemia cell lines. Oncogene, 12, 1005-1014 (1996).
3. CALL, K.M., GLASER, T., Im C.Y., BUCKLER, A.J., PELLETIER, J., HABER, D.A., ROSE, E.A., KRAL, A., YEGER, H., LEWIS, W.H., JONES, C. and HOUSMAN, D.E., Isolation and characterization of a zinc-finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60, 509-520 (1990).
4. EKERT, H., SIEVERS, E.L., TAN, A., MARTIN, D.I., SMITH, F.O., BARNARD, D. and BERNSTEIN. I.D., GATA-1 is expressed in acute erythroblastic leukaemia. Brit. J. Haemato., 86, 410-412 (1994).
5. FORT, P., MARTY, L., PIECHACZYK, M., EL SABROUTY, S., DANI, C., JEANTEUR, P. and BLANCHARD, J.M., Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13, 1431-1442 (1985).
6. FRAIZER, G.C., WU, Y.J., HEWITT, S.M., MAITY, T., TON, C.C.T., HUFF, V. and SAUNDERS, G.F., Transcriptional regulation of the human Wilms' tumor gene (WT1). J. biol. Chem., 269, 8892-8900 (1994).
7. GESSLER, M., POUSTKA, A., CAVENEE, W., NEVE, R.L., ORKIN, S.H. and BRUNS, G.A.P., Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (Lond.), 343, 774-778 (1990).
8. GUERRASIO, A., SAGLIO, G., Rosso, C., ALFARANO, A., CAMASCHELLA, C., COCO, F.L., BIONDI, A., RAMBALDI, A., NICOLIS, S. and OTTOLENGHI, S., Expression of GATA-1 mRNA in human myeloidleukemic cells. Leukemia, 8, 1034-1038 (1994).
9. MUGGINS, C.B. and SUGIYAMA, T., Induction of leukemia in rat by pulse doses of 7, 12-dimethylbenz[a]anthracene. Proc. nal. Acad. Sci. (Wash.), 55, 74-81 (1966).
10. INOUE, K. and 15 OTHERS, WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079 (1994).
11. KING-UNDERWOOD, L., RENSHAW, J. and PRITCHARD-JONES, K., Mutations in the Wilms tumor gene WT1 in leukemias. Blood, 87, 2171-2179 ( 1996).
12. LUO, X.N., REDDY, J.C., YEYATI, PL., IDRIS, A.H., HOSONO, S., HABER, D.A., LICHT, J.D. and ATWEH, G.F., The tumor-suppressor gene WT1 inhibits ras-mediated transformation. Oncogene, 11, 743-750 (1995).
13. MATSUDA, K., KOBUNE, Y., NODA, C. and ICHIHARA, A., Expression of GATA-binding transcription factors in rat hepatocytes. FEBS Lett., 353, 269-272 (1994).
14. MENSSEN, H.D., RENKL, H.J., RODECK, U., KARI, C., SCHWARTZ, S. and THIEL, E., Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia. Int. J. Cancer, 70, 518-523 (1997).
15. MENSSEN, H.D., RENKL, H.J., RODECK, U., MAURER, J., NOTIER, M., SCHWARTZ, S., RELNHARDT, R. and THIEL, E., Presence of Wilms' tumor gene (wt1) nuclear protein in the majority of human acute leukemias. Leukemia, 9, 1060-1067 (1995).
16. MIWA, H., BERAN, M. and SAUNDERS. G.F., Expression of the Wilms' tumor gene (WTI ) in human leukemias. Leukemia, 6, 405-409 ( 1992).
17. MIYAGI, T., AHUJA, H., KUBOTA, T., KUBONISHI, I., KOEFFLER, H.P. and MIYOSHI, I., Expression of the candidate Wilms' tumor aene WT1, in human leukemia cells. Leukemia, 7, 970-977 (1993).
18. ORKIN, S.H., GATA binding transcription factors in hematopoietic cells. Blood, 80, 575-581 (1992).
19. OSAKA, M., MATSUO, S., KOH, T., LIANG, P., KINOSHITA, H., MAEDA, S. and SUGIYAMA, T., N-ras mutation in 7, 12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in Long-Evans rats. Cancer Lett., 91, 25-31 (1995).
20. OSAKA, M., MATSUO, S., KOH, T. and SUGIYAMA, T., Specific N-ras mutation in bone marrow within 48 h of 7, 12-dimethylbenz[a|anthracene treatment in Huggins-Susiyama rat leukemogenesis. Mol. Carcinog., 16, 126-131 (1996).
21. OSAKA, M., MATSUO, S., KOH, T. and SUGIYAMA, T., Loss of heterozygosity at the N-ras locus in 7, 12-dimethylbenz[a]anthracene (DMBAj-induced rat leukemia. Mol. Carcinog, 18, 206-212 (1997).
22. PATMASIRIWAT, P., FRAIZER, G.G., CLAXTON, D., KANTARJIAN, H. and SAUNDERS, G.F., Expression pattern of WT1 and GATA-1 in AML with chromosome-16q22 abnormalities. Leukemia, 10, 1127-1133 ( 1996).
23. PHELAN, S.A., LINDBERG, C. and CALL, K.M., Wilms' tumor gene. WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth D iff., 5, 677-686 (1994).
24. PRIVITERA, E., SCHIRO, R., LONGONI, D., RONCHI, A., RAMBALDI, A., BERNASCONI, S., OTTOLENGHI, S., MASERA, G. and BIONDI, A., Constitutive expression of GATA-1, EPOR, α-globin. and γ-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia. Blood, 86, 323-328 (1995).
25. SEKIYA, M., ADACHI, M., HINODA, Y., IMAI, K. and YACHI, A., Down-regulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood, 83, 1876-1882 ( 1994).
26. SHARMA, P.M., YANG, X., BOEMSN, M., ROBERTS, V. and SUKUMAR, S., Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res., 52, 6407-6412 (1992).
27. SHIMAMOTO, T., OHYASHIKI, J.H., OIIYASHIKI, K., KAWAKUBO, K., KIMURA, N., NAKAZAWA, S. and TOYAMA, K., GATA-1, GATA-2 and stem cell leukemia gene expression in acute myeloid leukemia. Leukemia, 8, 1176-1180 (1994).
28. SUGIYAMA, T., KURITA, Y. and NISHIZUKA, Y., Biologic studies on 7, 12-dimethylbenz[a]amhracene-induced rat leukemia with special reference to the specific chromosomal abnormalities. Cancer Res., 29, 1117-1124 (1969).
29. WU, Y.J., FRAIZER, G.C. and SAUNDERS, G.F., GATA-1 transactivates the WT1 hematopoietic specific enhancer. J. biol. Chem., 270, 5944-5949 (1995).
30. YAMAGAMI, T., SUGIYAMA, H., INOUE, K., OGAWA, H., TATEKAWA, T., HlRATA, M., KUDOH. T., AKIYAMA, T., MURAKAMI, A., MAEKAWA, T. and KISHIMOTO, T., Growth inhibition of human leukemia cells by WT1 (Wilms tumor gene) antisense olisodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood, 87, 2878-2884 (1996).